Winfield Associates’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$937K Buy
6,837
+1,100
+19% +$146K 0.34% 70
2021
Q4
$808K Buy
5,737
+750
+15% +$99.6K 0.27% 78
2021
Q3
$635K Hold
4,987
0.23% 88
2021
Q2
$628K Hold
4,987
0.23% 90
2021
Q1
$582K Hold
4,987
0.24% 85
2020
Q4
$566K Hold
4,987
0.24% 81
2020
Q3
$526K Sell
4,987
-489
-9% -$51.5K 0.25% 78
2020
Q2
$548K Sell
5,476
-375
-6% -$37K 0.28% 74
2020
Q1
$518K Sell
5,851
-3,105
-35% -$302K 0.33% 64
2019
Q4
$912K Sell
8,956
-3,255
-27% -$313K 0.42% 61
2019
Q3
$1.1M Sell
12,211
-14,377
-54% -$1.31M 0.54% 51
2019
Q2
$2.46M Sell
26,588
-1,125
-4% -$101K 1.28% 20
2019
Q1
$2.54M Hold
27,713
1.36% 23
2018
Q4
$2.4M Buy
27,713
+2,110
+8% +$191K 1.47% 20
2018
Q3
$2.44M Buy
25,603
+593
+2% +$53.6K 1.2% 25
2018
Q2
$2.09M Sell
25,010
-778
-3% -$64.5K 1.12% 29
2018
Q1
$2.1M Sell
25,788
-2,050
-7% -$175K 1.13% 33
2017
Q4
$2.3M Sell
27,838
-981
-3% -$80.9K 1.16% 28
2017
Q3
$2.35M Buy
28,819
+705
+3% +$56.6K 1.24% 28
2017
Q2
$2.23M Buy
28,114
+1,800
+7% +$137K 1.23% 27
2017
Q1
$1.96M Sell
26,314
-615
-2% -$44.8K 1.11% 28
2016
Q4
$1.86M Sell
26,929
-950
-3% -$66K 1.14% 24
2016
Q3
$2.01M Buy
27,879
+1,545
+6% +$114K 1.26% 22
2016
Q2
$1.89M Sell
26,334
-1,062
-4% -$74.8K 1.23% 24
2016
Q1
$1.86M Sell
27,396
-800
-3% -$53.6K 1.26% 24
2015
Q4
$2.03M Buy
28,196
+230
+0.8% +$16.3K 1.36% 21
2015
Q3
$1.85M Sell
27,966
-565
-2% -$41.3K 1.38% 21
2015
Q2
$2.12M Buy
28,531
+1,990
+7% +$147K 1.45% 17
2015
Q1
$1.92M Buy
26,541
+5,399
+26% +$385K 1.35% 18
2014
Q4
$1.45M Buy
21,142
+1,895
+10% +$127K 1.06% 26
2014
Q3
$1.23M Buy
19,247
+375
+2% +$23.5K 0.92% 33
2014
Q2
$1.15M Buy
18,872
+2,336
+14% +$137K 0.83% 39
2014
Q1
$967K Buy
16,536
+4,167
+34% +$240K 0.8% 40
2013
Q4
$686K Buy
+12,369
New +$662K 0.56% 65

Other funds holding XLV

Winfield Associates's XLV Position: Q1 2022 in Review

Winfield Associates increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 19% in Q1 2022, buying an estimated $146K and bringing the position to 6,837 shares worth $937K. The position accounts for 0.34% of the portfolio, ranked #70.

Winfield Associates first reported a position in XLV in Q4 2013 and has held it in 34 quarters since. The position peaked at $2.54M in Q1 2019. 1,439 funds tracked by Wall St. Rank hold XLV as of Q1 2022.

  • Winfield Associates held 6,837 shares of State Street Health Care Select Sector SPDR ETF worth $937K as of Q1 2022.
  • Winfield Associates bought 1,100 State Street Health Care Select Sector SPDR ETF shares in Q1 2022, an estimated $146K.
  • State Street Health Care Select Sector SPDR ETF made up 0.34% of Winfield Associates's portfolio in Q1 2022, its #70 holding.
  • Winfield Associates first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2013 and has held it in 34 quarters since.
  • Winfield Associates's State Street Health Care Select Sector SPDR ETF position peaked at $2.54M in Q1 2019.
  • 1,439 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2022.

Based on Winfield Associates's 13F filing for Q1 2022, filed 5 Apr 2022.